The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

September 2020

Volume 16 Number 7

In valvular disease and heart failure a meta-analysis looks at the safety and efficacy of ViV-TAVI; an article examines the challenge of imaging and sizing in TAVI faced with abnormal aortic cusps; in coronary interventions defining complex PCIs from the large e-Ultimaster multicentre registry and a microfocus on intracoronary physiology indices with results from the HYPEREMIC trial on continuous IC adenosine infusion using a dedicated microcatheter; the diagnostic performance of OFR vs QFR; articles on new software to calculate vessel FFR (vFFR) or the optimisation of physiology-guided revascularisation in coronary disease; and a substudy of the DANAMI-3-PRIMULTI trial on FFR-guided PCI in patients with left ventricular hypertrophy.

Highlights from this issue

Comparison between OFR and QFR
Comparison between OFR and QFR
Huang J, Emori H, Ding D, Kubo T, Yu W, Huang P, Zhang S, Gutiérrez-Chico J, Akasaka T, Wijns W, Tu S
September 18, 2020
DOI: 10.4244/EIJ-D-19-01034
Long-term outcomes of complex PCI
Long-term outcomes of complex PCI
Mohamed M, Polad J, Hildick-Smith D, Bizeau O, Baisebenov R, Roffi M, Íñiguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas M
September 18, 2020
DOI: 10.4244/EIJ-D-20-00361

Interventions for valvular disease and heart failure

Coronary interventions - Mini focus: Physiology indices